Sarepta Therapeutics, Inc. (SRPT) Incremental Option Value Associated With The December2025Exchange — Quarterly & Annual

Screener

Incremental Option Value Associated With The December2025Exchange at other companies

Vitesse EnergyVTS

$0-100%

Liberty GlobalLBTYB

$0-100%

Iron MountainIRM

-$41.94M—

CBIZCBZ

36K—

SPS CommerceSPSC

52K-27.8%

DHI GroupDHX

1.2M—

Other financials

Income statement

Revenue$401.3M-34.3%

Operating income$13.3M-88.5%

Net income-$4.9M-102%

EPS (diluted)-$0.05-103%

Balance sheet

Cash & equivalents$571.1M+11.9%

Total debt$198.2M-7.6%

Total equity$1.5B+8.8%

Total assets$3.2B-13.4%

Cash flow

Operating cash flow-$202.7M+65.3%

CapEx$555.0K-98.3%

Free cash flow-$204.8M+67.3%

Valuation

Market cap$1.77B+1.1%

Enterprise value$1.4B-3.9%

P/S0.9×—

Profitability

Operating margin-50.8%-1.6pp

Net margin-6.9%—

FCF margin-28.7%-9.2pp

Returns & leverage

Return on equity-9.3%+2,662pp

Debt / equity0.1×0.0×

Current ratio4.4×+1.5×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept srpt:IncrementalOptionValueAssociatedWithTheDecember2025Exchange.

The source filing: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026. Open the filing →

Filed: Mar 2, 2026, 7:02 AM EST
Fiscal year: FY2025
Accession: 0001193125-26-084144

FAQ

What is Sarepta Therapeutics, Inc.'s incremental option value associated with the december2025exchange?: Sarepta Therapeutics, Inc. (SRPT) reported incremental option value associated with the december2025exchange of $5.27M in Q4 2025.
What does incremental option value associated with the december2025exchange mean?: Incremental Option Value Associated With The December2025Exchange as reported by Sarepta Therapeutics,, Inc. Common Stock.

Ask your AI about Sarepta Therapeutics, Inc.'s incremental option value associated with the december2025exchange.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk